Relationship Between Hypertension, Antihypertensive Drugs and Sexual Dysfunction in Men and Women: A Literature Review

Vasc Health Risk Manag. 2023 Nov 3:19:691-705. doi: 10.2147/VHRM.S439334. eCollection 2023.

Abstract

Sexual dysfunction pertains to any issue that hinders an individual from attaining sexual contentment. This health issue can have a significant impact on the quality of life and psychological health of affected individuals. Sexual dysfunction can generate stress, anxiety, depression, and low self-esteem, which can lead to a reduction in overall life satisfaction and the quality of interpersonal relationships. Sexual dysfunction can manifest as erectile dysfunction in men or lack of sexual desire in women. Although both sexes can experience sexual problems, there are some significant differences in the manifestation of sexual dysfunction between men and women. In men, sexual dysfunction is usually physical and associated with problems such as erectile dysfunction, while in women, sexual dysfunction is usually related to psychological factors. Additionally, there was an association between hypertension and sexual dysfunction in both the sexes. In men, hypertension can cause erection problems, whereas in women, it can cause vaginal dryness and a decrease in sexual desire. Furthermore, antihypertensive drugs can negatively impact sexual function, which can decrease adherence to drug treatment. However, nebivolol, an antihypertensive drug, has beneficial effects on erectile dysfunction in men. This is believed to be because nebivolol improves blood flow to the penis by producing nitric oxide, which can help improve erections.

Keywords: antihypertensive drugs; beta-blockers; erectile dysfunction; hypertension; nebivolol; sexual dysfunction.

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Erectile Dysfunction* / diagnosis
  • Erectile Dysfunction* / drug therapy
  • Erectile Dysfunction* / epidemiology
  • Female
  • Humans
  • Hypertension* / diagnosis
  • Hypertension* / drug therapy
  • Hypertension* / epidemiology
  • Male
  • Nebivolol / therapeutic use
  • Quality of Life / psychology

Substances

  • Antihypertensive Agents
  • Nebivolol

Grants and funding

This research received no external funding.